California Prepares for Fallout After US Withdraws from WHO; State Says It Will Seek Direct Global Disease Data
The United States completed its formal withdrawal from the World Health Organization on Jan. 22, 2026, ending funding, staff involvement and committee participation amid accusations over COVID-19 handling—a move raising concerns among global health experts and legal scholars.
- Withdrawal completed Jan. 22, 2026: The U.S. ended WHO membership after a one-year notice begun by Executive Order 14155.
- Federal plan: Officials say the U.S. will pursue bilateral disease-surveillance ties rather than rejoining WHO.
- Expert concern: Public-health authorities warn loss of WHO access could slow outbreak warnings and harm vaccine strain tracking.
- State-level claims: Reports that California will plug directly into global surveillance networks have not been publicly verified.
What happened: the process and timeline
The Trump administration set the withdrawal in motion on Jan. 20, 2025, with Executive Order 14155, citing what it described as WHO pandemic-response failures, delayed emergency declarations during COVID-19 and alleged concealment of information by member states. WHO rules require a one-year notice and settlement of obligations; the United States provided notice and completed the formal exit on Jan. 22, 2026. See statements from CDC and the WHO.
Actions taken at the end of the notice period included terminating U.S. funding to WHO programs, recalling U.S. personnel from WHO posts in Geneva and elsewhere, and suspending participation in WHO committees and technical groups — including influenza surveillance bodies. Officials say the U.S. will not serve as an observer and does not plan to rejoin. (See HHS and the State Department releases.)
Why the administration pulled out
The White House and federal health leaders argued WHO had not reformed after alleged failures during COVID-19. The administration framed the exit as a defense of U.S. sovereignty and an assertion that bilateral agreements would better serve American policy priorities. Officials criticized WHO for delayed actions and claimed insufficient independence from influence by certain member states. See the White House fact sheet and the joint State/HHS statement.
Financial dispute over unpaid dues
Money was a major sticking point. WHO officials say the U.S. owes roughly $133 million to $278 million in unpaid dues for 2024–2025 and contend withdrawal cannot be completed without settling obligations under WHO rules. The U.S. government disputes that interpretation and argues it is not obligated to pay under the WHO’s 1948 constitution; U.S. statements made clear the government would not make payments before withdrawal. (Reporting on the dispute: ABC7, CIDRAP.)
Expert and international reactions
Public-health experts and many international officials warned the exit could damage global health cooperation, reducing U.S. access to early outbreak warnings and weakening surveillance for influenza and other pathogens. The Global Influenza Surveillance and Response System (GISRS) was cited as an example of a network that helps select vaccine strains; experts worry bilateral arrangements may not replace that access quickly or fully.
“Shortsighted” and “scientifically reckless,” said the Infectious Diseases Society of America in response to the move.
WHO officials said they regret the decision and warned it would make countries less safe; the agency defended its pandemic work and planned to address the matter at upcoming Executive Board and World Health Assembly meetings. (See WHO statement.)
Legal and political questions
Legal scholars raised questions about whether a unilateral executive action is sufficient for withdrawal from an international organization that Congress once approved. Georgetown law professor Lawrence Gostin noted a congressional act may be required and indicated the matter could face legal challenge. The exit marks a break with prior U.S. policy: a Trump-era withdrawal attempt in 2020 was reversed by a subsequent administration; this administration completed the process under its stated authority. (See reporting at ABC7.)
What the U.S. says it will do next
Federal officials say they will forge direct bilateral relationships with other countries for disease surveillance and public-health priorities, bypassing WHO. Senior officials, including Secretary of State Marco Rubio and HHS Secretary Robert F. Kennedy Jr., issued a joint statement framing the move as necessary to protect national interests while preserving U.S. policy control. See the State Department joint statement and HHS release.
California response and claims about state action
Reports said California leaders, including Gov. Gavin Newsom, plan to build ties into global disease-tracking networks to protect nearly 39 million residents. However, a review of federal and state sources and news reporting found no publicly available documents or official announcements confirming specific California programs that independently replace WHO data streams. Assertions that California has formalized a direct plug into WHO-style networks could not be verified in the public record at this time. (See coverage: ABC7, ABC News, CDC.)
Implications for the United States
Early warning and surveillance: Experts warn the U.S. risks slower access to outbreak data if it relies on ad hoc bilateral arrangements instead of WHO networks; that could affect response speed and flu vaccine strain selection. (See CIDRAP and CDC reporting.)
National sovereignty and policy control: Supporters frame the withdrawal as restoring U.S. control over health policy and funding decisions; they argue bilateral ties will better align with American priorities. See the White House fact sheet.
Fiscal accountability: The administration’s refusal to pay disputed dues is framed as fiscal responsibility; the debate over legal obligations is likely to continue and could shape future negotiations. (Reporting: ABC7, CIDRAP.)
Public-health programs beyond pandemics: Critics warn that polio eradication, maternal and child health programs, and disease tracking (e.g., Ebola) could suffer if coordination through WHO weakens; those impacts may be felt indirectly in the U.S. via global disease trends, trade and travel. (See WHO coverage.)
Legal and diplomatic fallout: The move could prompt legal challenges at home and diplomatic friction abroad; the WHO plans to discuss the withdrawal at upcoming governance meetings and may press the matter with member states.
Reporting notes and sources
This report draws on federal statements and reporting by national outlets and public-health organizations, including HHS, the State Department, the CDC, the WHO, ABC News, ABC7, and CIDRAP.
